Швейцария - немски - Swissmedic (Swiss Agency for Therapeutic Products)

galderma sa - halcinonidum, ureum - creme - halcinonidum 1 mg, ureum 50 mg, antiox.: e 320, conserv.: triclosanum, chlorhexidini dihydrochloridum, excipiens ad-salbe für 1 g. - nicht infizierte, entzündliche dermatosen - synthetika

Швейцария - немски - Swissmedic (Swiss Agency for Therapeutic Products)

galderma sa - halcinonidum, ureum - fettcrème - halcinonidum 1 mg, ureum 100 mg, conserv.: triclosanum, chlorhexidini dihydrochloridum, excipiens ad-salbe für 1 g. - nicht infizierte, entzündliche dermatosen - synthetika

Швейцария - немски - Swissmedic (Swiss Agency for Therapeutic Products)

galderma sa - halcinonidum, acidum salicylicum - lösung - halcinonidum 1 mg, säure-salicylicum 20 mg, alcohol isopropylicus, antiox.: e 320, excipiens ad-lösung für 1 ml. - nicht infizierte, entzündliche hyperkeratotische und schuppende dermatosen an behaarten körperstellen - synthetika

Европейски съюз - немски - EMA (European Medicines Agency)

daiichi sankyo europe gmbh - trastuzumab deruxtecan - brustgeschwulste - antineoplastische mittel - breast cancerher2-positive breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-positive breast cancer who have received one or more prior anti-her2-based regimens. her2-low breast cancerenhertu as monotherapy is indicated for the treatment of adult patients with unresectable or metastatic her2-low breast cancer who have received prior chemotherapy in the metastatic setting or developed disease recurrence during or within 6 months of completing adjuvant chemotherapy (see section 4. non-small cell lung cancer (nsclc)enhertu as monotherapy is indicated for the treatment of adult patients with advanced nsclc whose tumours have an activating her2 (erbb2) mutation and who require systemic therapy following platinum-based chemotherapy with or without immunotherapy. gastric cancerenhertu as monotherapy is indicated for the treatment of adult patients with advanced her2-positive gastric or gastroesophageal junction (gej) adenocarcinoma who have received a prior trastuzumab-based regimen.

Австрия - немски - AGES (Agentur für Gesundheit und Ernährungssicherheit)

sanofi pasteur europe - bordetella pertussis; clostridium tetani (auszug, produkte); corynebacterium diphtheriae (auszug, produkte); poliomyelitisvirus - diphtherie-pertussis-po

Австрия - немски - AGES (Agentur für Gesundheit und Ernährungssicherheit)

sanofi pasteur msd snc - bordetella pertussis; clostridium tetani (auszug, produkte); corynebacterium diphtheriae (auszug, produkte); haemophilus spec. (auszug, produkte); poliomyelitisvirus - diphtherie-haemophilus-

Швейцария - немски - Swissmedic (Swiss Agency for Therapeutic Products)

daiichi sankyo (schweiz) ag - trastuzumabum deruxtecanum - pulver für ein konzentrat zur herstellung einer infusionslösung - praeparatio cryodesiccata: trastuzumabum deruxtecanum 100 mg, saccharum, histidinum, histidini hydrochloridum monohydricum, polysorbatum 80, pro vitro. - brustkrebs - biotechnologika

Германия - немски - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

dermapharm aktiengesellschaft (3326989) - amorolfinhydrochlorid - wirkstoffhaltiger nagellack - teil 1 - wirkstoffhaltiger nagellack; amorolfinhydrochlorid (23522) 55,74 milligramm

Германия - немски - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

trommsdorff gmbh & co. kg (3086350) - theophyllin - retardtablette - teil 1 - retardtablette; theophyllin (00323) 600 milligramm

Германия - немски - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

trommsdorff gmbh & co. kg (3086350) - thioctsäure - filmtablette - teil 1 - filmtablette; thioctsäure (02117) 600 milligramm